BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12911598)

  • 1. TRA-418, a novel compound having both thromboxane A(2) receptor antagonistic and prostaglandin I(2) receptor agonistic activities: its antiplatelet effects in human and animal platelets.
    Yamada N; Miyamoto M; Isogaya M; Suzuki M; Ikezawa S; Ohno M; Otake A; Umemura K
    J Thromb Haemost; 2003 Aug; 1(8):1813-9. PubMed ID: 12911598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRA-418, a thromboxane A2 receptor antagonist and prostacyclin receptor agonist, inhibits platelet-leukocyte interaction in human whole blood.
    Miyamoto M; Ohno M; Yamada N; Ohtake A; Matsushita T
    Thromb Haemost; 2010 Oct; 104(4):788-95. PubMed ID: 20664901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
    Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
    Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
    Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
    J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
    Yu SM; Wu TS; Teng CM
    Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of TRA-418, a novel TP-receptor antagonist, and IP-receptor agonist, on human platelet activation and aggregation.
    Miyamoto M; Yamada N; Ikezawa S; Ohno M; Otake A; Umemura K; Matsushita T
    Br J Pharmacol; 2003 Nov; 140(5):889-94. PubMed ID: 14504133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing an old drug for a new use: glybenclamide exerts antiplatelet activity by interacting with the thromboxane A(2) receptor.
    Ting HJ; Murray WJ; Khasawneh FT
    Acta Pharmacol Sin; 2010 Feb; 31(2):150-9. PubMed ID: 20139897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
    J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective modulation of the human platelet thromboxane A2/prostaglandin H2 receptor by eicosapentaenoic and docosahexaenoic acids in intact platelets and solubilized platelet membranes.
    Parent CA; Lagarde M; Venton DL; Le Breton GC
    J Biol Chem; 1992 Apr; 267(10):6541-7. PubMed ID: 1532390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries.
    Siangjong L; Gauthier KM; Pfister SL; Smyth EM; Campbell WB
    Am J Physiol Heart Circ Physiol; 2013 Feb; 304(3):H382-92. PubMed ID: 23203967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AGN 191976: a novel thromboxane A2-mimetic with ocular hypotensive properties.
    Krauss AH; Woodward DF; Chen J; Gibson LL; Lai RK; Protzman CE; Shan T; Williams LS; Gac TS; Burk RM
    J Ocul Pharmacol Ther; 1995; 11(3):203-12. PubMed ID: 8590251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet activity of 2-(6-carboxyhexyl)-3-n-hexylcyclohexylamine (IBI P-05006), a thromboxane receptor antagonist.
    Rotondo S; De Gaetano G; Cerletti C
    Eur J Pharmacol; 1993 Feb; 232(1):41-5. PubMed ID: 8384563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of luteolin‑4'‑O‑β‑D‑glucopyranoside on P2Y12 and thromboxane A2 receptor‑mediated amplification of platelet activation in vitro.
    Xu H; Lu H; Zhu X; Wang W; Zhang Z; Fu H; Ma S; Luo Y; Fu J
    Int J Mol Med; 2018 Jul; 42(1):615-624. PubMed ID: 29693158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1, 6-di-O-caffeoyl-β-D-glucopyranoside, a natural compound from Callicarpa nudiflora Hook impairs P2Y
    Fu J; Zhu X; Wang W; Lu H; Zhang Z; Liu T; Xu H; Fu H; Ma S; Luo Y
    Phytomedicine; 2017 Dec; 36():273-282. PubMed ID: 29157825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of ethanol extract of Piper longum L. on rabbit platelet aggregation through antagonizing thromboxane A2 receptor.
    Iwashita M; Saito M; Yamaguchi Y; Takagaki R; Nakahata N
    Biol Pharm Bull; 2007 Jul; 30(7):1221-5. PubMed ID: 17603157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.